Progyny, Inc. to Present at Jefferies London Healthcare Conference
Progyny (Nasdaq: PGNY), a provider of fertility, family building, and women's health benefits solutions, has announced its participation in the Jefferies London Healthcare Conference. CEO Pete Anevski and CFO Mark Livingston will engage in a fireside chat on Tuesday, November 19, 2024, at 8:00 a.m. GMT (3:00 a.m. EST).
Interested parties can access both the live audiocast and replay through the Events and Presentations section on Progyny's investor website at http://investors.progyny.com.
Progyny (Nasdaq: PGNY), fornitore di soluzioni per la fertilità, costruzione della famiglia e benefici per la salute delle donne, ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference. L'amministratore delegato Pete Anevski e il direttore finanziario Mark Livingston parteciperanno a una chiacchierata informale martedì 19 novembre 2024, alle 8:00 GMT (3:00 EST).
Le parti interessate possono accedere sia alla diretta che alla registrazione attraverso la sezione Eventi e Presentazioni sul sito web degli investitori di Progyny all'indirizzo http://investors.progyny.com.
Progyny (Nasdaq: PGNY), un proveedor de soluciones de fertilidad, construcción familiar y beneficios de salud para mujeres, ha anunciado su participación en la Conferencia de Salud de Jefferies en Londres. El director ejecutivo Pete Anevski y el director financiero Mark Livingston participarán en una charla informal el martes 19 de noviembre de 2024 a las 8:00 a.m. GMT (3:00 a.m. EST).
Los interesados pueden acceder tanto a la transmisión en vivo como a la repetición a través de la sección de Eventos y Presentaciones en el sitio web para inversores de Progyny en http://investors.progyny.com.
Progyny (Nasdaq: PGNY)는 불임, 가족 구성 및 여성 건강 혜택 솔루션 제공업체로서 제퍼리즈 런던 헬스케어 컨퍼런스에 참가한다고 발표했습니다. CEO인 Pete Anevski와 CFO인 Mark Livingston은 2024년 11월 19일 화요일 오전 8시 GMT (오전 3시 EST)에 파이어사이드 챗에 참여할 예정입니다.
관심 있는 분들은 Progyny의 투자자 웹사이트(http://investors.progyny.com)의 이벤트 및 프레젠테이션 섹션을 통해 라이브 오디오 방송과 재생을 모두 이용할 수 있습니다.
Progyny (Nasdaq: PGNY), fournisseur de solutions pour la fertilité, la construction familiale et les prestations de santé des femmes, a annoncé sa participation à la Conférence sur les soins de santé de Jefferies à Londres. Le PDG Pete Anevski et le directeur financier Mark Livingston participeront à une discussion informelle le mardi 19 novembre 2024 à 8h00 GMT (3h00 EST).
Les parties intéressées peuvent accéder à la fois à la diffusion audio en direct et à la rediffusion via la section Événements et Présentations sur le site Web des investisseurs de Progyny à l'adresse http://investors.progyny.com.
Progyny (Nasdaq: PGNY), ein Anbieter von Lösungen für Fruchtbarkeit, Familienplanung und Frauen-Gesundheitsleistungen, hat seine Teilnahme an der Jefferies London Healthcare Conference angekündigt. CEO Pete Anevski und CFO Mark Livingston werden am Dienstag, den 19. November 2024, um 8:00 Uhr GMT (3:00 Uhr EST) an einem informellen Gespräch teilnehmen.
Interessierte Parteien können sowohl auf den Live-Audiocast als auch auf die Wiedergabe im Bereich Veranstaltungen und Präsentationen auf der Investorenseite von Progyny unter http://investors.progyny.com zugreifen.
- None.
- None.
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 8:00 a.m. GMT (3:00 a.m. EST).
A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When is Progyny (PGNY) presenting at the Jefferies London Healthcare Conference 2024?
How can I watch Progyny's (PGNY) presentation at the Jefferies Healthcare Conference?
Who will represent Progyny (PGNY) at the Jefferies London Healthcare Conference 2024?
